Search
Powered by Google
Member Login
MHRA Criticizes EU Drug Verification Plan as Costly
5/14/2012
FDA Plans ID-Tag System to Detect Faulty Devices
4/25/2012
Legislation to establish medical device regulatory framework advances in Malaysia
How the FDA Stifles New Cures, Part II: 90% of Clinical Trial Costs are Incurred in Phase III
Scientists identify 'critical' gene for development and spread of lung cancer
Senate panel adds safety measures to FDA user fee act
US may lose chance to pass national drug trace plan
How the FDA Stifles New Cures, Part I: The Rising Cost of Clinical Trials
4/24/2012
Harvard urges faculty to ditch journals
US biopharma: "nearly 300 vaccines in R&D"
NIST Panel: FDA Should Regulate Device Cybersecurity, Hacking Risks
4/23/2012
Gasp -- ASP!
How Selective Hearing Works in the Brain
4/19/2012
Artificial DNA Can Replicate in Lab, Researchers Find
Drug Executives Tout R&D Spending As Industry Hits Patent Cliff
4/12/2012
Depression, Anxiety Tied to Physical Disabilities in Seniors
4/5/2012
Columbus Dispatch: The true cost
3/26/2012
The Hill: Medical device makers decry cost of new tax
Generic Drugs Proving Resistant to Damage Suits
3/20/2012
Big Pharma Saw an Almost One-Third Drop in Patent Filings Between 2007 and 2009
Biotech’s New Frontier: Europe?
3/19/2012
MDUFA Language Published, Public Meeting Set for March 28
MDUFMA: White House clears user fee proposal
3/15/2012
NCATS inks drug-screening partnership with Lilly
3/13/2012
FDA: 522 Reform Could Lead to More Discussions, Longer Response Time
3/12/2012
FDA Should Mandate NDAs Include Trial Data on Women: JAMA
How FDA, BIO differ on impact of accelerated approval reform in FAST, TREAT
GHTF Issues Guidance on IVD Clinical Performance Trials
3/5/2012
C Rad AB Receives FDA Approval of Catalyst System
FDA’s China Inspection Plan Draws Praise, Criticism as 2013 Budget Hearings Open
3/2/2012
Generic Drugs Will Gain 80 Percent of Market for First Time in 2012
Experts Question True ‘Abbreviation’ of Biosimilars Approvals Pathway
Draft Guidance Outlines Designs for Drug Interaction Studies
2/29/2012
Elsevier Abandons Anti-Open Access Bill
2/28/2012
FDA’s Margaret Hamburg Takes On Drug Shortages
2/24/2012
Austerity in Europe Puts Pressure on Drug Prices
2/23/2012
Boston Scientific Corp. Receives FDA Approval For Drug-Eluting Coronary Stent Use In Heart Attack Patients
2/22/2012
US FDA 510(k) clearance for Elekta's Fraxion
2/21/2012
Medical Innovation: How the U.S. Can Retain Its Lead
2/14/2012
FDA's new budget heavily reliant on user fees
2/13/2012
U.S. FDA sets draft rules for biotech drug copies
2/9/2012
Chemists Harvest Light to Create 'Green' Tool for Pharmaceuticals
DNA Sequencing Helps Identify Cancer Cells for Immune System Attack
2/8/2012
Delays in MDUFA Agreement Threaten Omnibus User Fee Bill
WHITE: FDA’s assault on mobile technologies
2/7/2012
FDA pushes worldwide, uniform device code
2/6/2012
Congressional Democrats Seek to Fix Flaws in Med Device Approval Process
2/3/2012
Gloom for the pharma industry, yes. Doom? No.
FDA commish counters industry critics on expert conflict rules
Pharma defeats biotech push for rapid approval program
2/2/2012
Quick PDUFA Passage Threatened by Delayed Medical Device User Fee Agreement
Collaborations Hold the Potential to Reinvent Drug Development
Klobuchar, Paulsen Meet with FDA Commissioner to Discuss Improving Medical Device Approval Process, Encouraging Innovation
2/1/2012
FDA's new-drug approvals of 2011
Device industry, FDA ink $595M user-fee deal
Funding bill may address drug shortages-aides
1/31/2012
Russia to Release New Medical Device Regulations
1/26/2012
US FDA sets 30 June deadline for finalising companion Dx guidance
House GOP to offer health reform 'replace' plan after SCOTUS rules
Pharma's Focus On Rare Disease Drugs Spurs US Aid For Antibiotics
1/25/2012
Early Success in a Human Embryonic Stem Cell Trial to Treat Blindness
1/24/2012
Dwarfism Medicine Shows Lure of $400,000 Drugs for Rare Diseases
1/23/2012
S.B.A. Readying Program to Invest in Start-Ups
Stent advances expected to prop up European market
1/19/2012
Wiring the Brain, Literally, to Treat Stubborn Disorders
1/18/2012
Generics market to boom as blockbusters go off-patent
1/17/2012
FDA Misses MDUFA Deadline, Putting Legislation in Jeopardy
US pharma: 282 meds for children now in R&D
1/13/2012
NY falls to No. 3 for venture capital activity
1/12/2012
EU Proposes Centralized Expert Group to Oversee Medical Devices
1/10/2012
Survey: 8 in 10 California CEOs blame FDA for slowing growth
FDA to create drug interaction alert app
1/9/2012
EU to set new biosimilar drug rules by mid-year
1/6/2012
Stimulating white blood cells to fight HIV
Stem cells in eyes offer hope for reversing leading cause of blindness in seniors
1/5/2012
FDA Piloting Risk-Benefit Decisionmaking Framework
1/4/2012
FDA Devises Flow Chart to Guide 510(k) Evaluations
FDA Requests Comments on Communications and Activities Related to Off-Label Uses of Marketed Products
1/3/2012
Tongue-Depressor Tax Will Harm Jobs, Innovation: Ramesh Ponnuru
1/2/2012
IOM Insists That Feds More Carefully Oversee IT Vendors
1/1/2012
FDA releases draft guidance on medical device applications
12/29/2011
FDA Targets Risks From Reused Devices
12/28/2011
Sunshine Act Compliance Delayed to 2013 Under CMS Proposed Rule
12/20/2011
Medical Devices Need Follow Up After U.S. Approval, Senators Say
12/16/2011
Bill Would Require More Monitoring of Implants
12/14/2011
FDA seeks comment on post-market drug safety plans
12/13/2011
Paulsen, Altmire Lead Bipartisan Effort to Increase Efficiency at the FDA
10/14/2011
U.S. FDA guidance on biosimilars may be imminent
9/23/2011
Public Policy Institute study shows the biopharmaceutical sector should be a growth engine for New York’s economy
4/12/2011
Watson, come here. A deep-thinking physicians' assistant makes a lot of sense
3/23/2011
Today Is: Thursday, May 17, 2012
May Events
Full calendar | Add to Outlook/iCal